Cresco Labs (CRLBF) Gains from Investment Securities (2020 - 2026)

Cresco Labs has reported Gains from Investment Securities for 7 years, with the latest figure at -$1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities rose 20.7% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 21.09% YoY), and the FY2025 full-year result was $4.7 million, down 48.48% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$1.4 million, down from $18.4 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $73.6 million in Q4 2023, with the low at -$42.6 million in Q4 2022.
• Historically, Gains from Investment Securities has averaged $4.8 million across 5 years, with a median of $238000.0 in 2024.
• The largest YoY upside for Gains from Investment Securities was 727.49% in 2022 against a maximum downside of 1440.83% in 2022.
• Cresco Labs' Gains from Investment Securities stood at -$42.6 million in 2022, then soared by 272.64% to $73.6 million in 2023, then plunged by 110.67% to -$7.8 million in 2024, then soared by 334.88% to $18.4 million in 2025, then sank by 107.46% to -$1.4 million in 2026.
• The last three Gains from Investment Securities figures came in at -$1.4 million (Q1 2026), $18.4 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.